CRONUS PHARMA, LLC – Trademark Portfolio
Entity Type: 16
CRONUS PHARMA, LLC holds 47 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 46 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 16 are pending. Notable registered marks include ANASED, YOBINE, FLUNINE, DORAJECT, and BUTORPHIC. The owner is based in EAST BRUNSWICK, NJ.
2 TOWER CENTER BOULEVARD
EAST BRUNSWICK, NJ 08816
Showing of trademarks Trademarks
Trademark Classifications
CRONUS PHARMA, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CRONUS PHARMA, LLC have?
CRONUS PHARMA, LLC has 47 U.S. trademarks filed with the USPTO. Of these, 10 registered, 16 pending, 18 abandoned, 3 cancelled.
What trademark classes does CRONUS PHARMA, LLC file in?
CRONUS PHARMA, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CRONUS PHARMA, LLC's most well-known trademarks?
CRONUS PHARMA, LLC's registered trademark portfolio includes well-known marks such as ANASED, YOBINE, FLUNINE, DORAJECT, and BUTORPHIC. These are among 10 currently registered trademarks in the portfolio.
What is CRONUS PHARMA, LLC's trademark registration success rate?
CRONUS PHARMA, LLC has a 32% trademark registration rate, with 10 out of 31 resolved applications resulting in successful registration. Currently, 16 applications are pending review.